All Stories

  1. Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer’s Disease
  2. Prevalence of Comorbid Dementia in Late-life Depression and Bipolar Disorder: A Retrospective Inpatient Study
  3. Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer’s Disease
  4. Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases
  5. PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression
  6. TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer’s Disease
  7. MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer's disease
  8. TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects
  9. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease
  10. Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment
  11. INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects
  12. DNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia Subjects
  13. Endothelial nitric oxide synthase in rat brain is downregulated by sub-chronic antidepressant treatment
  14. Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer’s Disease
  15. Elevated mRNA expression of CASPR3 in patients with schizophrenia
  16. Gene expression-based biological test for major depressive disorder: an advanced study
  17. 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder
  18. DNA methylation changes atSNCAintron 1 in patients with dementia with Lewy bodies
  19. Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer’s Disease Subjects
  20. Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects
  21. Elevated TREM2 mRNA expression in leukocytes in schizophrenia but not major depressive disorder
  22. Neural basis of visual perception and reasoning ability in Alzheimer's disease: correlation between Raven's Colored Progressive Matrices test and123I-IMP SPECT imaging results
  23. Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder
  24. Association Study and Meta-Analysis of Polymorphisms, Methylation Profiles, and Peripheral mRNA Expression of the Serotonin Transporter Gene in Patients with Alzheimer's Disease
  25. Risk of idiopathic normal pressure hydrocephalus in older inpatients with schizophrenia
  26. Risk factors for refeeding hypophosphatemia in Japanese inpatients with anorexia nervosa
  27. TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer’s Disease and Schizophrenia
  28. Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese population
  29. Biological tests for major depressive disorder that involve leukocyte gene expression assays
  30. Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation
  31. Risk of bipolar disorder and psychotic features in patients initially hospitalised with severe depression
  32. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson’s disease
  33. Psychiatric symptoms in a patient with isolated adrenocorticotropin deficiency: case report and literature review
  34. Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection
  35. Microarray analysis of global gene expression in leukocytes following lithium treatment
  36. Depression in X-linked dystonia-parkinsonism: A case–control study
  37. Association Study of Fat-mass and Obesity-associated Gene and Body Mass Index in Japanese Patients with Schizophrenia and Healthy Subjects
  38. DNA Methylation Signatures of Peripheral Leukocytes in Schizophrenia
  39. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder
  40. Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese population
  41. GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study
  42. Association Study Between the Pericentrin (PCNT) Gene and Schizophrenia
  43. Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population
  44. No association between Rho-associated coiled-coil forming protein serine/threonine kinase1 gene and schizophrenia in the Japanese population
  45. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)
  46. Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population
  47. Predictors of subjective and objective quality of life in outpatients with schizophrenia
  48. TGFBR2 gene expression and genetic association with schizophrenia
  49. FKBP5, SERT and COMT mRNA expressions in the peripheral leukocytes during menstruation cycle in healthy reproductive females
  50. No association between the NDE1 gene and schizophrenia in the Japanese population
  51. Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia
  52. Molecular assessment of depression from mRNAs in the peripheral leukocytes
  53. Association between PNPO and schizophrenia in the Japanese population
  54. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder
  55. Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression
  56. Gene expression in the peripheral leukocytes and association analysis of PDLIM5 gene in schizophrenia
  57. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients
  58. SUBJECTIVE AND OBJECTIVE MEASURES OF QUALITY OF LIFE HAVE DIFFERENT PREDICTORS FOR PEOPLE WITH SCHIZOPHRENIA1,2
  59. Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia
  60. Gene expression and association analysis of LIM (PDLIM5) in major depression
  61. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms
  62. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms
  63. Mood swing from severe depression to mania following acute alteration of thyroid status
  64. Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine
  65. ACUTE ABDOMINAL DISTENSION SECONDARY TO URINARY RETENTION IN A PATIENT AFTER ALCOHOL WITHDRAWAL
  66. A CASE OF KORSAKOFF'S SYNDROME IMPROVED BY HIGH DOSES OF DONEPEZIL